Recombinant Human monoclonal antibody expressed in CHO binding to Human CXC-ELR. The antibodiess specifically bind seven human ELR+ CXC chemokines are useful for treating various inflammatory/autoimmune diseases, such as inflammatory bowel disease (IBD), plaque psoriasis, and palmoplantar pustulosis; and cancer, such as renal cancer or ovarian cancer.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-097MZ | Human Anti-CXC-ELR Recombinant Antibody (TAB-097MZ) | Neutralizing Assay, WB | Humanized antibody |
TAB-098MZ | Anti-Human CXC-ELR Recombinant Antibody (PanELR) | Binding assay | Humanized antibody |
TAB-099MZ | Anti-Human CXC-ELR Recombinant Antibody (PanELR(PE)) | Binding assay | Humanized antibody |
TAB-100MZ | Anti-Human CXC-ELR Recombinant Antibody (PanELR(PE)N297A) | Binding assay | Humanized antibody |
TAB-101MZ | Anti-Human CXC-ELR Recombinant Antibody (PanELR(PE)N297S ) | Binding assay | Humanized antibody |
There are currently no Customer reviews or questions for TAB-197CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.